Tokyo, June 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061828) titled 'Research to visualize the health promoting effects of chiropractic treatment' on June 8.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -but assessor(s) are blinded
Control - Dose comparison
Primary Sponsor:
Institute - iFoodMed inc.
Condition:
Condition - Not applicable (Healthy adult)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study focuses particularly on immunity, which is deeply involved in health promotion, and comprehensively evaluates QOL (SF-36) before and after chiropractic intervention, along with saliva-derived biomarkers (IgA, cortisol, Beta-defensin, CRP) and body temperature, to non-invasively and quantitatively analyze the health-promoting effects of chiropractic treatment. This aims to visualize the health-promoting effects of simple and practical chiropractic intervention.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - A group receiving chiropractic treatment once a week for eight consecutive weeks (each session lasting approximately 40 minutes, with a low intensity).
Interventions/Control_2 - A group receiving chiropractic treatment once a week for eight consecutive weeks (each session lasting approximately 40 minutes, with a high intensity).
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - Individuals who have received a thorough explanation of the research's purpose and content, fully understood it, and voluntarily volunteered to participate and agreed to participate in the research.
Key exclusion criteria - 1) Individuals with a serious underlying medical condition
2) Individuals undergoing immunosuppressive therapy
3) Pregnant individuals
4) Individuals experiencing oral symptoms accompanied by bleeding, such as bleeding gums
5) Individuals who are scheduled to receive the same chiropractic treatment within two weeks prior to the start of the study.
Target Size - 70
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2026 Year 05 Month 15 Day
Date of IRB - 2026 Year 05 Month 15 Day
Anticipated trial start date - 2026 Year 05 Month 18 Day
Last follow-up date - 2027 Year 08 Month 09 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070729
Disclaimer: Curated by HT Syndication.